Based the results of a completed scoping review, this interactive presentation aims to highlight what is known about medications for opioid use disorder (MOUD) treatment during the novel-coronavirus-2019 (COVID-19) pandemic in correctional institutions around the world. Participants will learn about MOUD, its utility in correctional facilities, and what is known about the impact of COVID-19 on MOUD programs in correctional settings. The presenter will describe innovations described in the literature which facilitated the continuation of MOUD services. Additionally, challenges associated with the use of these tools will be explored. Suggestions will be drawn from the literature to translate this learning to future program planning, research, and care delivery. These suggestions include areas of potential practice change, room for advocacy, and opportunities for leadership support.

Medications for Opioid Use Disorder in Correctional Facilities During COVID Times: Highlighting Changes, Innovations, and Opportunities for Growth (PID080)

Speakers

Caralee Anderson RN. BScN.